http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 09 Feb 2026 08:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html <p align="justify">ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“<strong>Ascentage Pharma</strong>” or the “<strong>Company,</strong> a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company&apos;s management is scheduled to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 being held on February 11-12, 2026.  </p> <p align="justify">The management team will be participating in a fireside chat at 9:30 am EST on Thursday, February 12th. The webcast can be http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+Guggenheim+Emerging+Outlook%3A+Biotech+Summit+2026/25965105.html Mon, 09 Feb 2026 08:00:00 -0500 36X 6855 A.07309385 A.10141387 A.20922990 A.23936186 A.60001765 AAPG O.00048977 O.04944854 O.20043539 O.20059298 O.20738543 O.38659577